|
| | Publication Year | Title | Author(s) |
| 181 | 12-Dec-2013 | Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer. | Jonker, D J; Karapetis, C S; Harbison, C; O'Callaghan, Christopher J ; Tu, D; Simes, R J; Malone, D P; Langer, C; Tebbutt, Niall C ; Price, Timothy J; Shapiro, J; Siu, L L; Wong, R P W; Bjarnason, G; Moore, M J; Zalcberg, John R; Khambata-Ford, S |
| 182 | 23-May-2022 | Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression. | Luk, Ian Y; Jenkins, Laura J; Schoffer, Kael L; Ng, Irvin; Tse, Janson W T; Mouradov, Dmitri; Kaczmarczyk, Stanislaw; Nightingale, Rebecca; Burrows, Allan D; Anderson, Robin L ; Arango, Diego; Dopeso, Higinio; Croft, Larry; Richardson, Mark F; Sieber, Oliver M; Liao, Yang; Mooi, Jennifer K ; Vukelic, Natalia; Reehorst, Camilla M; Afshar-Sterle, Shoukat ; Whitehall, Vicki L J; Fennell, Lochlan; Abud, Helen E; Tebbutt, Niall C ; Phillips, Wayne A; Williams, David S ; Shi, Wei; Mielke, Lisa A; Ernst, Matthias ; Dhillon, Amardeep S; Clemons, Nicholas J; Mariadason, John M |
| 183 | 23-Oct-2008 | Established, emerging and future roles of PET/CT in the management of colorectal cancer. | Herbertson, R A; Scarsbrook, A F; Lee, S T; Tebbutt, Niall C ; Scott, Andrew M |
| 184 | Jan-2023 | Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database. | Margalit, Ofer; Harmsen, William S; Shacham-Shmueli, Einat; Voss, Molly M; Boursi, Ben; Wagner, Anna D; Cohen, Romain; Olswold, Curtis L; Saltz, Leonard B; Goldstein, Daniel A; Hurwitz, Herbert; Tebbutt, Niall C ; Kabbinavar, Fairooz F; Adams, Richard A; Chibaudel, Benoist; Grothey, Axel; Yoshino, Takayuki; Zalcberg, John; de Gramont, Aimery; Shi, Qian; Lenz, Heinz-Josef |
| 185 | 26-Dec-2023 | Evaluating the Educational Value of Cancer Registries - a Systematic Review and Thematic Analysis. | Lin, James; Temperley, Hugo C; Larkins, Kirsten; Waters, Caitlin; Chong, Kit Loong; Maida, Jack; Proud, David ; Burgess, Adele N ; Heriot, Alexander; Smart, Philip J ; Mohan, Helen |
| 186 | 7-Mar-2023 | Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial. | Gupta, Arjun; O'Callaghan, Christopher J ; Zhu, Liting; Jonker, Derek J; Wong, Ralph P W; Colwell, Bruce; Moore, Malcolm J; Karapetis, Christos S; Tebbutt, Niall C ; Shapiro, Jeremy D; Tu, Dongsheng; Booth, Christopher M |
| 187 | 17-Mar-2021 | Evaluation of 18F-FMISO PET and 18F-FDG PET Scans in Assessing the Therapeutic Response of Patients With Metastatic Colorectal Cancer Treated With Anti-Angiogenic Therapy. | Lee, Sze Ting ; Tebbutt, Niall C ; Gan, Hui K ; Liu, Zhanqi; Sachinidis, John; Pathmaraj, Kunthi ; Scott, Andrew M |
| 188 | Jul-2024 | Evaluation of a repeated web-based screening procedure to detect anxiety and depression symptoms in Day Oncology patients | Luong, Hoang K; Wrench, Joanne M ; Suryanarayan, Neha; Davies, Alicia; Howatt, Claire; Seidel-Marks, Leigh; Tebbutt, Niall C ; Wilson, Carlene J |
| 189 | 1-Sep-2020 | Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers: Subgroup Analysis of a Phase 2 Nonrandomized Clinical Trial. | Klein, Oliver ; Kee, Damien ; Nagrial, Adnan; Markman, Ben; Underhill, Craig; Michael, Michael; Jackett, Louise A ; Lum, Caroline; Behren, Andreas; Palmer, Jodie ; Tebbutt, Niall C ; Carlino, Matteo S; Cebon, Jonathan S |
| 190 | 4-Sep-2019 | Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer. | Burzykowski, Tomasz; Coart, Elisabeth; Saad, Everardo D; Shi, Qian; Sommeijer, Dirkje W; Bokemeyer, Carsten; Díaz-Rubio, Eduardo; Douillard, Jean-Yves; Falcone, Alfredo; Fuchs, Charles S; Goldberg, Richard M; Hecht, J Randolph; Hoff, Paulo M; Hurwitz, Herbert; Kabbinavar, Fairooz F; Koopman, Miriam; Maughan, Timothy S; Punt, Cornelis J A; Saltz, Leonard; Schmoll, Hans-Joachim; Seymour, Matthew T; Tebbutt, Niall C ; Tournigand, Christophe; Van Cutsem, Eric; de Gramont, Aimery; Zalcberg, John R; Buyse, Marc |
| 191 | 22-Feb-2023 | Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer. | Verhoek, Andre; Cheema, Parneet; Melosky, Barbara; Samson, Benoit; Shepherd, Frances A; de Marinis, Filippo; John, Thomas ; Wu, Yi-Long; Heeg, Bart; Van Dalfsen, Nadia; Bracke, Benjamin; Miranda, Miguel; Shaw, Simon; Moldaver, Daniel |
| 192 | 1-Nov-2014 | Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranib. | Richter, Suzanne; Seah, Jo-An; Pond, Gregory R; Gan, Hui K ; Mackenzie, Mary J; Hotte, Sebastien J; Mukherjee, Som D; Murray, Nevin; Kollmannsberger, Christian; Heng, Daniel; Haider, Masoom A; Halford, Robert; Ivy, S Percy; Moore, Malcolm J; Sridhar, Srikala S |
| 193 | 29-Apr-2021 | Evaluation of TMB as a predictive biomarker in patients with solid cancers treated with anti-PD-1/CTLA-4 combination immunotherapy. | Klein, Oliver ; Kee, Damien ; Markman, Ben; Carlino, Matteo S; Underhill, Craig; Palmer, Jodie ; Power, Daniel; Cebon, Jonathan S ; Behren, Andreas |
| 194 | 16-Sep-2013 | Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study. | Ohtsu, Atsushi; Ajani, Jaffer A; Bai, Yu-Xian; Bang, Yung-Jue; Chung, Hyun-Cheol; Pan, Hong-Ming; Sahmoud, Tarek; Shen, Lin; Yeh, Kun-Huei; Chin, Keisho; Muro, Kei; Kim, Yeul Hong; Ferry, David; Tebbutt, Niall C ; Al-Batran, Salah-Eddin; Smith, Heind; Costantini, Chiara; Rizvi, Syed; Lebwohl, David; Van Cutsem, Eric |
| 195 | 6-Jul-2017 | Evolution of anti-HER2 therapies for cancer treatment | Parakh, Sagun ; Gan, Hui K ; Parslow, Adam C; Burvenich, Ingrid JG; Burgess, Antony W; Scott, Andrew M |
| 196 | 1-Apr-2015 | Evolving treatment paradigms in lung cancer: role of immuno-oncology. | Mitchell, Paul L R |
| 17 | 24-May-2021 | Excess mortality and undertreatment in elderly lung cancer patients: treatment nihilism in the modern era? | Pham, Jonathan; Conron, Matthew; Wright, Gavin; Mitchell, Paul L R ; Ball, David; Philip, Jennifer; Brand, Margaret; Zalcberg, John; Stirling, Rob G |
| 18 | 13-Apr-2007 | The expanding role of PET technology in the management of patients with colorectal cancer. | Herbertson, R A; Lee, S T; Tebbutt, Niall C ; Scott, Andrew M |
| 19 | 12-Nov-2012 | Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies. | Starmans, Maud Hw; Pintilie, Melania; John, Thomas ; Der, Sandy D; Shepherd, Frances A; Jurisica, Igor; Lambin, Philippe; Tsao, Ming-Sound; Boutros, Paul C |
| 20 | 2023 | Exploring the educational value of the general surgical outpatient clinic: a systematic review. | Rostolis, Renee; Temperley, Hugo C; Larkins, Kirsten; Burgess, Adele N ; Proud, David ; Mohan, Helen |
